Surfactants have been used as a tool to improve the properties of polymeric nanoparticles (NPs) and to increase the rate of hydrophobic drug release by means of these nanoparticles. In this context, this study evaluated the effect of lecithin on the characteristics of chitosan (CHI) and chondroitin sulfate (CS) nanoparticles, when applied in curcumin (Curc) release.
Trang 1Contents lists available atScienceDirect
Carbohydrate Polymers journal homepage:www.elsevier.com/locate/carbpol
The role of the lecithin addition in the properties and cytotoxic activity of
chitosan and chondroitin sulfate nanoparticles containing curcumin
Katiúscia Vieira Jardima, Joseilma Luciana Neves Siqueirab, Sônia Nair Báob,
Marcelo Henrique Sousaa, Alexandre Luis Parizec,⁎
a Green Nanotechnology Group, Universidade de Brasília, Brasília, DF 72220-900, Brazil
b Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília, CampusUniversitário Darcy Ribeiro – Asa Norte, Brasília, DF 70910-900,
Brazil
c Polimat, Grupo de Estudos em Materiais Poliméricos, Departamento de Química, Universidade Federal de Santa Catarina, Florianópolis, SC 88040-900, Brazil
A R T I C L E I N F O
Keywords:
Chitosan
Chondroitin sulfate
Lecithin
Curcumin
Polymeric nanoparticles
Drug delivery
A B S T R A C T Surfactants have been used as a tool to improve the properties of polymeric nanoparticles (NPs) and to increase the rate of hydrophobic drug release by means of these nanoparticles In this context, this study evaluated the
effect of lecithin on the characteristics of chitosan (CHI) and chondroitin sulfate (CS) nanoparticles, when ap-plied in curcumin (Curc) release CHI/CS NPs and CHI/CS/Lecithin NPs were prepared by the ionic gelation method, both as standards and containing curcumin Simultaneous conductimetric and potentiometric titrations were employed to optimize the interaction between the polymers NPs with hydrodynamic diameter of∼130 nm and zeta potential of +60 mV were obtained and characterized by HRTEM; their pore size and surface area were also analyzed by BET method, DLS, FTIR, XPS, andfluorescence spectroscopy techniques to assess morphological and surface properties, stability and interaction between polymers and to quantify the loading of drugs Thefinal characteristics of NPs were directly influenced by lecithin addition, exhibiting enhanced encapsulation efficiency
of curcumin (131.8μg curcumin per mg CHI/CS/Lecithin/Curc NPs) The release of curcumin occurred gradually through a two-stage process: diffusion-controlled dissolution and release of curcumin controlled by dissolution of the polymer However, the release of curcumin in buffer solution at pH 7.4 was achieved faster in CHI/CS/ Lecithin/Curc NPs than in CHI/CS/Curc NPs in vitro cytotoxic activity evaluation of the curcumin was de-termined by the MTT assay, observing that free curcumin and curcumin nanoencapsulated in CHI/CS/Curc and CHI/CS/Lecithin/Curc NPs reduced the viability of MCF-7 cells in the 72 h period (by 28.4, 36.0 and 30.7%,
P < 0.0001, respectively) These results indicate that CHI/CS/Lecithin NPs have more appropriate character-istics for encapsulation of curcumin
1 Introduction
Curcumin (1,7bis
(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a yellow solid, classified according to the
Biopharmaceutics Classification System (BCS) as a class II drug that is
poorly water-soluble but highly permeable It is a phenolic compound
that has methoxy and phenol groups in its chemical composition, which
are responsible for its biological and pharmacological properties (Dai
et al., 2018) Its potential in the prevention and treatment of various
diseases, including cancer, has been extensively investigated in recent
years, since it has antiproliferative and pro-apoptotic effects against
several types of tumors, contributing mainly to the inhibition of tumor
growth (Calaf, Ponce-Cusi, & Carrión, 2018) Recently,Siddiqui et al
(2018)showed that curcumin decreases the Warburg effect on several cancer cells (H1299, MCF-7, HeLa and PC3) Similarly, Davatgaran-Taghipour et al (2017)presented experimental evidence and clinical perspectives that polyphenols such as curcumin are potentially capable
of acting as chemopreventive and chemotherapeutic agents in different types of cancer In addition, the authors report that nanoformulations of natural polyphenols as bioactive agents, including resveratrol, cur-cumin, quercetin, epigallocatechin-3-gallate, chrysin, baicalin, luteolin, honokiol, silibinin and coumarin derivatives, in a dose-dependent manner, result in prevention and treatment of cancer However,Nelson, Dahlin, Bisson, Graham, Pauli & Walters (2017)reported in their study that although the activity and therapeutic utility of curcumin have in-creased the interest of scientists, no evidence of the therapeutic benefits
https://doi.org/10.1016/j.carbpol.2019.115351
Received 11 February 2019; Received in revised form 4 July 2019; Accepted 18 September 2019
⁎Corresponding author
E-mail address:alexandre.parize@ufsc.br(A.L Parize)
Available online 21 September 2019
0144-8617/ © 2019 Elsevier Ltd All rights reserved
T
Trang 2of curcumin has been found The authors claim that curcumin has
disadvantages as a candidate in the clinical setting, since it has low
solubility in aqueous solutions, high decomposition rate in neutral or
basic pH and susceptibility to photochemical degradation, which is also
reported in other studies (Chuah, Roberts, Billa, Abdullah, & Rosli,
2014;Lim et al., 2018) However, considering these controversies
re-garding the therapeutic efficacy of curcumin,Heger (2017)suggests
that the thousands of research papers and more than 120 clinical trials
performed with curcumin should not be discarded; it is particularly
worth further investigating its potential as a therapeutic agent In this
context, several strategies have been evaluated to increase the
biolo-gical activity of curcumin, mainly aiming for greater absorption and
availability to tissues (Akbar et al., 2018)
Several methods are described in the literature for improving the
solubility of curcumin, such as: impregnation (Parize et al., 2009),
li-posomes (Li et al., 2018), copolymers and nanoemulsions (Akbar et al.,
2018;Dai et al., 2018), chemical modifications in curcumin structure
(Mohamed, El-Shishtawy, Al-Bar, & Al-Najada, 2017), and association
in polymer nanoparticles (Jardim, Joanitti, Azevedo, & Parize, 2015),
among others Polymeric nanoparticles appear as easy-to-prepare
sys-tems and increase the effectiveness of the treatment, due to the
in-creased solubility and inin-creased effectiveness of the drug Recently,
nanoparticles formed from chitosan and chondroitin sulfate through
ionic polyelectrolytic complexation have been reported as a promising
alternative for the encapsulation and release of hydrophobic drugs,
such as curcumin, since it is a simple and reversible process (Umerska,
Corrigan, & Tajber, 2017) In addition, NPs formed through ionic
cross-linking have the ability to protect the active substance against
de-gradation and increase its bioavailability in a physiological
environ-ment (Tsai, Chen, Bai, & Chen, 2011) Chitosan can also be associated
with biocompatible surfactants, such as lecithin, which promotes
im-provements in the properties of the polymer network that is formed, as
well as an increase in the incorporation rate of the drug (Dammak &
Sobral, 2018;Şenyiğit et al., 2017;Terrón-Mejía et al., 2018)
Chitosan is a natural biopolymer obtained from the reaction of
N-deacetylation of chitin in alkaline medium It is represented as a
co-polymer of 2-amine-2-deoxy-D-glucose and
2-acetamide-2-deoxy-D-glucose, linked byβ-type glycosidic bonds (1,4) It has a wide range of
applications because it is biodegradable, biocompatible, bioadhesive
and non-toxic (Biswas, Chattopadhyay, Sen, & Saha, 2015;
Terrón-Mejía et al., 2018) When dissolved in aqueous acid solutions, pH <
6.2 has a positive charge in the−NH3+groups, which facilitates their
solvation in water and aggregation to polyanionic compounds, such as
chondroitin sulfate, forming polyelectrolyte complexes (PECs) (Şenyiğit
et al., 2017;Terrón-Mejía et al., 2018)
Chondroitin sulfate belongs to the family of glycosaminaglans
(GAGs), and it is characterized as an alternating copolymer of the
monomers β(1,4)-D-glucuronic acid and β(1,3)-N-acetyl-D-
galactosa-mine, which may be sulfated at the C4or C6carbons It has low toxicity,
biocompatibility and specific biodegradability (Krichen et al., 2018) In
addition, it can form polyelectrolyte complexes (PECs) through
elec-trostatic interaction with positively charged substances, thus providing
an optimal strategy to maintain CS in the solid state for use as a drug
delivery system (Jardim et al., 2015;Gul et al., 2018; Tan, Selig, &
Abbaspourrad, 2018)
Nanoparticles based on PECs formed by biopolymers do not often
promote adequate dispersion, solubilization and bioavailability of
drugs such as curcumin Thus, to promote greater stability and e
ffi-ciency in the encapsulation of poorly soluble drugs, a coating with
biocompatible compounds, such as lecithin, is required (Sun et al.,
2015) Lecithin is a highly bioactive compound that consists of a
gly-cerol backbone esterified with two fatty acids and a phosphate group,
endowing it with strong potential for use in the food and
pharmaceu-tical industries as an emulsifier, nutrition enhancer and carrier (Pawar
& Babu, 2014) The nanoparticles prepared with lecithin and chitosan
showed higher bioavailability, mucoadhesive property, storage stability
and enhanced efficiency in the encapsulation of drugs (Shin, Chung, Kim, Joung, & Park, 2013;Yang, Dai, Sun, & Gao, 2018;Tsai, Chiu, Lin, Chen, Huang, & Wang, 2011)
In this context, the objective of this study was to evaluate the effect
of adding lecithin on the characteristics of chitosan (CHI) and chon-droitin sulfate (CS) nanoparticles, prepared by the ionic gelation method, used for the controlled in vitro release of curcumin and to improve its cytotoxic activity in human breast tumor cells (MCF-7)
2 Materials and methods
Chitosan (99% purity) (medium molecular weight) with a molecular mass around 106 kg mol−1 and deacetylation degree ∼76.9% was determined by conductimetric titration (Alvarenga, 2011) Chondroitin 4-sulfate sodium salt (99% purity), originating from bovine trachea and curcumin (95% purity), originating from Curcuma Longa L., with purity
of 98%, were obtained from Sigma-Aldrich (St Louis, MO, USA) Le-cithin obtained from egg yolk (60% of L-α-Phosphatidylcholine – Sigma Aldrich Dulbecco's Modified Eagle Medium (DMEM) and 3-(4,5-di-methyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) were obtained from Life Technologies (USA), and the line of human breast tumor cells (MCF-7) was obtained from the cell bank of Rio de Janeiro (BCRJ), Brazil The other reagents were of analytical grade and were used without prior purification
2.1 Sample elaboration
The logarithmic values of the dissociation constant (pKa =−logKa) were determined for pure CHI and CS samples, by means of simulta-neous potentiometric and conductimetric titrations as described by Farris, Mora, Capretti, and Piergiovanni (2012), to optimize conditions
of interaction between the polymers during synthesis of NPs In this way, 50 mL of the CHI or CS solutions (0.1 wt%) were titrated with a 0.1 mol.L−1HCl or NaOH solution, using a Metrohm 856 Conductivity Module with a 5-ring conductivity measuring cell (c =0.7 cm−1with Pt1000) and a Metrohm 827 pH lab pHmeter Before titration, the pH of the CS and CHI solution were respectively adjusted to∼2.0 and ∼7.0, using HCl and NaOH solutions Based on the pKa values, the speciation diagram of the mole fractions of the surface sites as a function of pH was constructed, thus establishing the ideal pH (5.5) for obtaining the nanoparticles
The synthesis of CHI/CS and CHI/CS/Lecithin NPs was performed
by the ionic gelation method (Fan, Yan, Xu, & Ni, 2012) For this, homogeneous solutions of CHI (1.0 mg/mL) and CS (1.0 mg/mL) were prepared in 0.1 mol.L−1acetic acid solution and pH adjusted to∼5.5
To obtain the CHI/CS NPs, 150 mL of CS solution was added slowly to
100 mL of CHI solution The CHI/CS/Lecithin NPs were obtained with the addition of 5.0 mL of 3.5% (w/v) of lecithin ethanol solution to
100 mL of CHI solution, and then 150 mL of the chondroitin sulfate solution was added slowly The lecithin-chitosan ratio was set at 1:20 (w/w) in the nanoparticles The formation of the NPs was conducted under constant magnetic stirring for 40 min at 25 °C
The encapsulation of curcumin into the CHI/CS NPs was carried out
by adding an ethanolic solution of curcumin to the CHI solution prior to the interaction with the CS solution The following synthetic metho-dology is the same as that described in the previous paragraph in re-lation to the production of the CHI/CS NPs based on a previous study by Jardim et al (2015) A small amount of curcumin (∼30 mg) was added, and stabilized in 100 mL of the CHI solution, which was maintained at
pH 5.5 After the curcumin had come into contact with the chitosan solutions, the 150 mL of CS solution at pH 5.5 was added slowly to the solution containing CHI/Curc The solutions were maintained under constant magnetic stirring for 40 min at 25 °C, leading to the formation
of CHI/CS/Curc NPs The incorporation of curcumin in the CHI/CS/ Lecithin NPs occurred prior to the addition of 5.0 mL of 3.5% (w/v) of lecithin ethanol solution to 100 mL of CHI solution at pH 5.5 and then
Trang 3was added to curcumin (˜ 30 mg) and 150 mL of CS solution at pH 5.5.
The solutions were also maintained under constant magnetic stirring for
about 40 min at 25 °C, leading to the formation of CHI/CS/Lecithin/
Curc NPs
2.2 Sample characterization
The morphology and size of the prepared NPs was evaluated by
high-resolution transmission electron microscopy (HRTEM) using a
JEOL JEM-2100 microscope equipped with EDS, Thermo scientific For
HRTEM analysis, the colloidal suspensions obtained were diluted in
water in a ratio of 50μL of the colloidal suspension of NPs to 100 μL of
Type 1 water A small aliquot of the resulting sample dilution (3μL) was
placed on a copper screen (400 mesh), covered with a carbonfilm and,
before the measurements were taken, a solution of phosphotungstic
acid (2.0% w/v) was applied to provide contrast for better visualization
of NPs under the microscope
Dynamic light scattering (DLS) (Nano-Zetasizer-ZS, Malvern
Instruments) was used to determine the hydrodynamic diameter, the
polydispersity index (PDI) and the zeta potential of the NPs as a
func-tion of pH For DLS analysis, the NPs were dispersed in water (about
0.01 wt%), sonicated for 10 min and pH adjusted with 0.1 mol.L−1of
the HCl or NaOH solutions
The surface area and pore volume distribution of the NPs were
measured using a mass of 0.2 g sample at 77 K in AUTOSORB-1
equipment with a free space of about 16 cm³, cold free space around 48
cm³, equilibrium interval of 10 s, no low pressure dose and automatic
degassing
The stability of the nanoparticles was evaluated by monitoring the
hydrodynamic diameter and the zeta potential, using Dynamic light
scattering (DLS) equipment (Nano-Zetasizer-ZS, Malvern Instruments)
The samples were kept at 37 °C in the form of aqueous suspension, and
the measurements were performed in triplicate, using a diluted solution
(0.01 wt%) of the samples, during the period of 90 days The
inter-pretation of data was performed by cumulative analysis of the
experi-mental correlation function, and hydrodynamic radius was calculated
from the computed diffusion coefficients using the Stokes–Einstein
equation (Eq 2)
=
πηD
6
h
where Dtis the diffusion coefficient, k is the Boltzmann constant, T is
the absolute temperature, η is the dynamic viscosity and Rh is the
particle diameter
The FTIR spectra were recorded with KBr pellets in the region of
4000–400 cm−1on a Varian FTIR spectrophotometer with a resolution
of 2 cm−1
By means of X-ray photoelectron spectrometry (XPS), strains were
acquired in a SPECS SAGE HR 100 system spectrometer, with energy of
30 eV and 15 eV for analysis of the regions and of 285 eV for calibration
of the binding energies of the peak C 1s The atomic percentage of the
elements present on the surface of the NPs under study and their
pos-sible interactions were determined
2.3 Determination of curcumin loading
In the quantification of curcumin, performed by the
filtration/cen-trifugation technique (Sun, Me, Tian, & Liu, 2007), the free active was
determined in the supernatant and the total active was measured after
the complete dissolution of the samples To obtain the supernatant,
10 mg of nanoparticle-based samples were dispersed in 10 mL of an
80:20 (v/v) mixture of 0.1 mol.L−1 phosphate buffer solution (pH
7.4):ethanol Afterfiltering through 0.2 μm PTFE filter, an aliquot of the
supernatant was transferred to a quartz cell and analyzed in a
Fluor-olog-TSPC (Horiba-Jovine Ivone)fluorimeter Both slits of excitation
and emission monochromators were adjusted to 5.0 nm The samples
were excited at 429 nm, and the emission spectra were recorded from
440 to 700 nm The relativefluorescence intensities were measured at λ
= 540 nm and compared to a standard calibration curve To construct the calibration curve, a stock solution of 108μmol.L−1curcumin was prepared in a 80:20 (v/v) mixture of 0.1 mol.L−1solution of phosphate
buffer solution (pH 7.4):ethanol From the stock solutions, the working solutions were prepared at concentrations of 0.5 to 15μmol.L−1 by dilutions of the stock solution in the phosphate buffer solution (pH 7.4):ethanol solution Each sample was assayed in triplicate, and the results were expressed as the amount of curcumin (inμg) per mg of nanoparticles Similarly, the encapsulation efficiency (EE%) was cal-culated as the ratio between the amount of drug entrapped in the na-noparticles and the initial amount of curcumin used to prepare the nanoparticle batch
2.4 Curcumin release profile The kinetics of curcumin release was performed by adapting the methodology described byParize et al (2009) For this purpose, ap-proximately 30 mg of curcumin-containing CHI/CS/Curc and CHI/CS/ Lecithin/Curc NPs were suspended in 30 mL of 0.1 mol.L−1phosphate
buffer solution at pH 7.4 The samples were kept under constant stirring (700 rpm) in a thermostat-controlled bath at 37.0 ± 0.1 °C The ana-lysis was conducted for 240 h by means of measurements at pre-determined time intervals, where a 2 mL aliquot of the supernatant was analyzed on a Fluorolog-TSPC (Horiba-Jovine Ivone)fluorimeter with both slits of excitation, and emission monochromators were adjusted to 5.0 nm The samples were excited at 429 nm, and the emission spectra were recorded from 440 to 700 nm The amount of curcumin released was determined using the Curc calibration curves, which correlate the fluorescence intensity with the known concentration of curcumin (μmol/L) in the same solution where release kinetics was conducted The results obtained were presented as percentage of release of cur-cumin over time The release mechanism was analyzed by adjusting the release kinetics profiles, applying the Gallagher-Corrigan mathematical model (Gallagher & Corrigan, 2000)
2.5 Biological tests
2.5.1 Evaluation of in vitro cytotoxic activity For the cell culture, the human breast epithelial adenocarcinoma cell line (MCF-7) was routinely maintained in cell culture flasks (75 cm2) in an incubator (37 °C, 5% CO2and 98% humidity) with 15 mL
of DMEM cell culture medium supplemented with 10% (v/v) fetal bo-vine serum (FBS, Life Technologies, USA) and 1% (v/v) antibiotic so-lution (100 U/mL penicillin – 100 μg/mL streptomycin, Life Technologies, USA) and passaged every 3 or 4 days For the passage or preparation of the experiments, the cells were desalted with 1 mL of 0.25% Trypsin-EDTA (Life Technologies, USA) and then inactivated with 5 mL DMEM supplemented with 10% FBS and 1% antibiotic so-lution
Cell viability was determined by the 3,4,5-dimethylthiazol-2,5-bi-phenyl tetrazolium bromide (MTT) assay, where MCF-7 cells (5 × 103 cells/well in 200μL of DMEM) were seeded on 96-well plates and al-lowed to attach overnight Cells were then incubated with 200μL/well
of DMEM containing different concentrations (10 to 40 μmol.L−1) of CHI/CS and CHI/CS/Lecithin NPs (with or without curcumin) and free curcumin at 37 °C (5% CO2) The pH of the samples was adjusted to 7.4 with NaOH (1.0 mol.L−1) before being seeded with the cells After 24,
48 and 72 h of incubation, the treatment was withdrawn and then
150μL of MTT solution (0.5 mg/mL in DMEM) was added in each well, and incubation was carried out for 3 h at 37 °C (5% CO2) The culture medium was then aspirated, and 200μL of dimethyl sulfoxide was added to dissolve the purple formazan crystals from viable cells The absorbance was determined using a spectrophotometer with a micro-plate reader at a wavelength of 595 nm (SpectraMax®, model M2,
Trang 4Molecular Devices, USA) This absorbance reading is directly
propor-tional to the number of live cells in the culture The percentage of cell
viability was presented as the percentage of the absorbance of treated
cells to the absorbance of non-treated cells (100% × (absorbance of
treated cells / absorbance of non-treated)
2.5.2 Internalization study of samples in MCF-7 cells
For the analysis of sample internalization, 1 × 106MCF-7 cells/well
were seeded on 6-well culture plates and, after adhesion, the cells were
exposed to 40μmol.L−1free curcumin, CHI/CS/Curc NPs and CHI/CS/
Lecithin/Curc NPs for 24 h The desalted cells in microtubes were then
washed with PBS and fixed with Karnovsky's solution (2.0%
glutar-aldehyde, 2.0% paraformglutar-aldehyde, 5.0 mmol CaCl2, 3.0% sucrose
buf-fered in 0.1 mol.L−1sodium cacodylate, at pH 7.2) for 2 h at 4 °C After
fixation, the cells were washed in the same buffer and post-fixed for
30 min in 1% osmium tetroxide, 0.8% potassium ferricyanide and
5.0 mmol CaCl2in 0.1 mol.L−1 sodium cacodylate buffer Cells were
washed twice with ultrapure water and then stained with 0.5% uranyl
acetate overnight at 4 °C The samples were washed twice with
ultra-pure water and dehydrated in increasing acetone gradient (50–100%)
for 10 min each and included in Spurr resin The ultrafine sections were
obtained with an ultra-microtome (Leica, UCT, AG, Vienna, Austria)
and analyzed in a JEOL JEM-2100 transmission electron microscope
equipped with EDS, Thermo scientific
2.5.3 Statistical analysis
All results are from three independent experiments and expressed as
the mean ± SD The difference between the effect of the treated
compound compared with the control values was verified by analysis of
variance (ANOVA) and Tukey's post hoc test using the program
GraphPad Prism® 5.0 The values that were significantly different from
the control at P < 0.05 are indicated in the Figures by an asterisk
3 Results and discussion
Chitosan and chondroitin sulfate are polyfunctional polymers (with
−NH2and−SO3H and−COOH groups, respectively) that can be
io-nized in aqueous medium, where chitosan is represented by CHI-NH3+/
CHI-NH2 and chondroitin sulfate as CS−COOH−SO3H/
CS−COO−−SO3 − in their protonated/deprotonated forms
Considering that ionic crosslinking is based on the attractive
electro-static interaction between the CHI and CS polymers, it will be governed
by the number of ionizable surface sites of the polymers, which depends
directly on the pH of the dispersions (Maldonado, Terán, & Guzmán,
2012) Thus, before the preparation of the nanoparticles, the speciation
profiles were constructed in order to determine the ideal pH to optimize
the attractive interaction between the surface of the CHI and the CS
polymers, by means of their pKa values obtained by simultaneous
po-tentiometric and conductometric titrations (Fig 1)
In the CHI titration (Fig 1A) two distinct zones were observed In
zone 1, before adding the titrant (HCl), the pH of the CHI dispersion is
∼7.2 and the −NH2groups are expected to be substantially
deproto-nated/discharged As the titrant is added, the protonation of NH2
groups occurs and CHI becomes positively charged Conductivity of CHI
solution, low before adding the titrant, sharply increases at the
equivalence point (pH 4.7) as an excess of titrant is added (zone 2)
(Farris et al., 2012) Cross-linking conductometric and potentiometric
data, a pKa = 6.3 was estimated for CHI In the titration curves of the
CS (Fig 1B), three zones were observed In thefirst zone, as the titrant
(NaOH) is added, a reduction in the conductivity is due to the
neu-tralization of the excess of H3O+ions (from HCl, used to adjust the
initial pH), reaching thefirst point of equivalence (pH ∼1.9) In the
second zone, the variation of conductivity is due to the deprotonation of
the sulfonic and carboxylic groups (i.e [H3O+] increasing) and [Na+]
variation, from the titrant (Scordilis-Kelley & Osteryoung, 1996) Thus,
the second equivalence point (pH∼7.4) was reached after the complete
deprotonation of the−SO3H and−COOH groups, where the third zone
is initiated In the third zone, there was a sharp increase in the con-ductivity due to the excess of OH− ions in the dispersion For CS, pKa1= 2.5 (−SO3H) and pKa2= 4.0 (−COOH) were estimated from titration data as described byCampos, Tourinho, Da Silva, Lara, and Depeyrot (2001)
Thus, taking into account the pKa values obtained in the titrations, the molar fraction of polymer surface species was plotted against the
pH, as shown inFig 1C In these speciation curves, it was verified that
CS presents three distinct superficial sites In an extremely acidic medium, protonated sulfonic and carboxylic groups (CS-SO3H−COOH) are observed With the progressive increase of pH, sequential depro-tonation of the sulfonic and carboxylic groups occurs Thus, the surface
of CS becomes negatively charged (−SO3 − and−COO−), allowing complexation with positively charged species in neutral and alkaline pHs (Rodrigues, Cardoso, Da Costa, & Grenha, 2015) However, at these pHs the CHI remains deprotonated, as shown in speciation curves On the other hand, in an acidic medium the CHI is positively charged, because of the protonation of−NH2groups (CHI−NH3+) Considering these speciation diagrams, at a pH halfway between the pKa of CHI and
pK2of CS (pH ∼5.5) most superficial sites of CHI will be positively charged and CS will be negatively charged Thus, the optimized inter-action between CHI and CS can occur (Menegucci, Santos, Dias, Chaker,
& Sousa, 2015)
Also inFig 1C, we observe the dependence of the zeta potential as a function of pH variation (2.0–12.0) of the CHI/CS NP dispersions From this curve, it was found that at pH < 7.0 zeta potential becomes po-sitive and increases as pH decreases This is associated with the pro-tonation of amine groups of CHI Above pH∼7.0, an increasingly ne-gative zeta potential was observed and associated with the deprotonation of−SO3H and−COOH groups This change in the zeta potential of the NPs confirms that the polymers are pH-responsive, i.e., the degree of ionization is significantly altered by virtue of a variation
in the pH near the pKa value of their functional groups (Ganta, Devalapally, Shahiwala, & Amiji, 2008)
This speciation study improved the ionic gelation method, favoring the formation of NPs with a narrow distribution and hydrodynamic diameter in the range of nanometers, as shown inTable 1 Besides, the addition of lecithin resulted in the reduction of the hydrodynamic diameter and the PDI of the NPs (Table 1) The reduction in the hy-drodynamic diameter of the nanoparticles after addition of lecithin may
be related to the contribution of the attractive hydrophobic and elec-trostatic interactions that occur between the polymer and the surfac-tant This effect may be associated with the less effective overlap of electrostatic potentials around the polymer chain (Khan & Brettmann,
2019) In addition, the presence of the surfactant may cause changes in the behavior of the polymer in solution, such as surfactant-induced thickening, surfactant-induced swelling or compaction, surfactant-in-duced phase separation, among other effects (Silva, Antunes, Sousa, Valente, & Pais, 2011) Banik, Hussain, Ramteke, Sharma, and Maji (2012)also suggest that the surfactant may decrease the solubility of chitosan, favoring the formation of small particles On the other hand,
an increase in the zeta potential of lecithin-containing NPs was ob-served due to the amine headgroup of choline present in the surfactant structure, which increases the positive charge density on the surface of NPs (Cheng, Oh, Wang, Raghavan, & Tung, 2014)
The positive zeta potential with a relatively high modulus value (at
pH ∼5.5) efficiently promoted curcumin encapsulation (Table 1) However, it was also observed that the amount of encapsulated cur-cumin was higher in CHI/CS/Lecithin/Curc NPs (131.8μg/mg) than in CHI/CS/Curc NPs (118.4μg/mg) This occurs because the negatively charged polar portion (phosphate groups) of the lecithin interacts with the−NH3+groups of CHI, leading to the preliminary formation of a vesicle The self-assembling of phospholipid with the polymer leaves the fatty-acid positively-charged polar chains available to interact with the hydrophobic part of curcumin (Taner et al., 2014) In addition, the
Trang 5use of the lecithin in the internal phase increased the wettability of the
solid particles of the drug, facilitating its adsorption on the
nano-particles (Chen et al., 2016) After encapsulation of the curcumin, an
increase in the hydrodynamic diameter, the PDI and the zeta potential
of the NPs was observed, as shown inTable 1 This indicates the success
in the encapsulation of the drug, which causes changes in the
char-acteristics of the NPs (Marturano, Cerruti, Giamberini, Tylkowski, &
Ambrogi, 2017)
From the adsorption/desorption isotherms of N2obtained by BET
(data not shown) the presence of micropores (pore diameter < 20 Å) in
the NPs was confirmed (Sing et al., 1985) The formation of the
mi-cropores may be related to the cross-linked bonds established between
the biopolymers during the synthesis process (Lu, Le, Zhang, Huang, &
Chen, 2017) From the BET results (Table 1) it was also observed that
an increase occurred in the surface area of the NPs after addition of
lecithin surfactant The presence of the surfactant reduces the
interfacial tension, resulting in the increase of the surface area and consequently the reduction of the size of the nanoparticles (Wen, Wen, Wei, Zushun, & Hong, 2012) This indicates that the selective cavities of NPs were more exposed after the addition of lecithin, allowing a greater encapsulation of curcumin In addition, it was verified that the increase
in surface area is directly proportional to the increase in the mean volume of pores; however, there is an inverse correlation between the surface area, the hydrodynamic and pore diameters in all NPs (Marturano et al., 2017) In the NPs containing curcumin, it was ob-served that the values of surface area and mean volume of pores were relatively lower, when compared to the values obtained for NPs without curcumin, indicating the encapsulation of the drug, which causes changes in the characteristics of NPs (Silva, Fideles, & Fook, 2015)
In prolonged periods of storage, NPs of this kind of material tend to form agglomerates (Kumari, Yadav, & Yadav, 2010) It is therefore a great challenge to produce systems that keep their colloidal stability for
Fig 1 Potentiometric (●) and conductometric (○) titration: CHI (A) and CS (B) Speciation diagram of the surface of CHI ( CHI-NH3+and CHI-NH2) and CS ( CS-SO3H−COOH, CS-SO3 −−COOH and CS-SO3 −−COO−) (C) Representation of the chemical interactions between CHI and CS in obtaining the NPs by ionic gelation
Table 1
Values for the size, PDI and zeta potential of the CHI/CS and CHI/CS/Lecithin and encapsulation efficiency (EE%) of curcumin
Samples Size (nm) a PDI a Zeta potential
(mV) a
BET analyses Curcumin Loading
Amount of curcumin encapsulated (μg/mg) a
Encapsulation efficiency (%EE) a
Surface area (m 2 /g)
Pore volume (cm 3 /g)
Pore diameter (Å) CHI/CS 111.7 ± 1,8 0.299 ± 0.03 58.2 ± 1.3 28.9 0.043 13.1 – –
CHI/CS/Lecithin 102.2 ± 1,5 0.224 ± 0.02 60.7 ± 1.1 33.8 0.054 11.5 – –
CHI/CS/Curc 154.6 ± 1.3 0.391 ± 0.02 59.7 ± 1.1 19.5 0.029 17.6 118.4 ± 0.1 78.6 ± 0.4%
CHI/CS/Lecithin/
Curc
126.2 ± 1.6 0.339 ± 0.02 60.4 ± 1.2 23.6 0.035 15.4 131.8 ± 0.2 87.5 ± 0.5%
a Mean ± SD, n = 3
Trang 6a long time Taking this into account, the stability of NP suspensions
stored at 37 °C was monitored relative to the hydrodynamic diameter
and zeta potential during the 90-day period The pH of samples was also
monitored in this period and varied from 5.5 to 6.0 The results
ob-tained are shown inFig 2, where it can be verified that the zeta
po-tential of NPs remained stable and positive, with a high modulus value
(> +40 mV), as expected at this pH, indicating that there are large
repulsive forces in the system, reducing the possibility of NP
aggrega-tion (Tsai, Chen et al., 2011) The CHI/CS/Lecithin NPs did not show
statistically significant variations in relation to the hydrodynamic
dia-meter during the 90-day period However, the CHI/CS NPs presented an
increase of approximately 30% in relation to the original hydrodynamic
diameter of the NPs over this period These results show that the
ad-dition of the surfactant reduces theflocculation of the particles, giving
greater stability to the NPs Similar results were obtained for NPs
containing curcumin
As observed in the transmission electron micrograph displayed in
Fig 3, the morphology of the NPs developed in this study corresponds
to a compact structure with a tendency to exhibit a spherical shape, as
has been described for many formulations of polysaccharide-based
nanoparticles prepared by polyelectrolyte complexation (Hu, Chiang,
Hong, & Yeh, 2012) However, the particle size observed with TEM
(∼35 nm) was smaller compared to the result determined by DLS This
discrepancy can be most likely explained as the shrinking of the
na-noparticles during the drying process prior to the TEM observation The
inset ofFig 3(corresponding to the micrograph of CHI/CS/Lecithin/
Curc NPs) shows a compact lipid nucleus surrounded by a contrasting
layer of chitosan and chondroitin sulfate, confirming the presence of
the polymers as the outmost layer surrounding the curcumin–lecithin
complex, as the result of expected electrostatic interaction, based on
opposite charges Similar results were observed by (Sonvico et al.,
2006;Souza et al., 2014)
The FTIR spectra (Fig 4) present the main bands of the chemical groups present in the NPs and their possible interactions In the spec-trum of all the NPs a band at 1020 cm−1 assigned to the groups
NH3+−SO3 − was observed, indicating the interaction between the polymers (Jardim et al., 2015) In addition, the characteristic bands of chitosan, such as 1377-1257 cm-1relative to the C–N bond, 1153 cm−1
attributed to the CeOeC bond of β 1–4 glucose, and 1072-1029 cm−1
due to the angular deformation of the amine group, were observed in the spectra of the NPs The presence of chondroitin sulfate was also confirmed in the spectra of the NPs by the observation of the bands: 1238-1060 cm−1and 856 cm−1 assigned to the S]O and CeOeS bonds, respectively In the CHI/CS and CHI/CS/Curc NPs spectra (Fig 4c and 4e) a shift was observed in the bands at 1658 cm−1to
1639 cm−1 assigned to the amide I and at 1593 cm−1 to1559 cm−1 related to the angular deformation of the amine group This last shift indicates that the NH2 group in the NPs is in the form of NH3+
(Guilherme et al., 2010;Parize, Stulzer, Laranjeira, Brighente, & Souza,
2012)
In the spectra of the NPs containing curcumin (Fig 4e and4f) the band shift at 1593 cm−1 to 1558 cm−1 relative to NH2 of CHI was observed, indicating the interaction between the amine group of CHI and the phenolic group of curcumin The stretches at 3451 cm−1 as-signed to the phenolic−OH group at 1620 cm−1relative to the C]O bond of the conjugated ketone were also observed at 1562-1420 cm−1 related to the C]C bond of the aromatic ring, at 1380 cm−1referring to
Fig 2 Stability of the NPs at 37 °C for the period of 90 days in function of the hydro-dynamic diameter (A) and Zeta potential (B) for: (●) CHI/CS NPs; ( ) CHI/CS/Lecithin NPs; ( ) CHI/CS/Curc NPs and ( ) CHI/CS/Lecithin/ Curc NPs
Fig 3 TEM images of CHI/CS/Lecithin/Curc NPs with different
magnifica-tions Histogram of particle diameters is shown in lower-right inset
Fig 4 FTIR spectra for a) CHI; b) CS c) CHI/CS NPs; d) CHI/CS/Lecithin NPs, e) CHI/CS/Curc NPs, f) CHI/CS/Lecithin/Curc NPs and g) Curcumin
Trang 7the CH3groups and at 1070 cm−1referring to the CeOeC vibration of
the ether These bands were also observed in the curcumin spectrum
(Fig 4g) (Anitha et al., 2011;Jardim et al., 2015;Şenyiğit et al., 2017)
The presence of the band at 1593 cm−1 corresponding to the
de-formation of the amine group from CHI was not observed inFig 4d and
4f, indicating the interaction of the NH2groups of CHI with the
phos-phate groups of lecithin in an acid medium In the spectra of the
le-cithin-containing samples (Fig 4d and4f), the following bands were
observed: 3423 cm−1and 3437 cm−1were attributed to the stretches of
the amine group; 1705 cm−1corresponded to the carbonyl of the fatty
acids present in lecithin, and the bands at 1053 cm−1were related to
the vibration of the phosphate group (Şenyiğit et al., 2017)
The NPs were also analyzed by XPS to characterize their surface
chemically and to evaluate the possible interactions between the
polymers (Table 2) The composition obtained for CHI (54.5% C, 39.7%
O and 5.8% N) is in agreement with the data obtained in the XPS
analysis performed by Rodrigues, Da Costa, and Grenha (2012) The
elemental composition of CS was found (50.2% C, 41.8% O, 4.9% N and
3.1% S) In the NPs only the elements carbon (C), oxygen (O), nitrogen
(N) and sulfur (S) present in the chemical structures of their precursors
were identified, indicating the absence of contamination during the
synthesis process However, in NPs containing lecithin, the presence of
phosphorus (P) and an increase in the atomic percentage of N was
observed, indicating the contribution of the surfactant in the NPs The
encapsulation of curcumin in the samples was further confirmed based
on the increase in the O/C atomic mass ratio in the NPs containing
curcumin CHI/CS/Curc NPs (1.3%) and CHI/CS/Lecithin/Curc NPs
(1.6%) when compared to NPs without curcumin: CHC/CS NPs (0.7%)
and CHI/CS/Lecithin NPs (0.9%)
InFig 5, the general aspect of the in vitro release curves obtained for
curcumin from the CHI/CS/Curc and CHI/CS/Lecithin/Curc NPs can be seen, performed at 37 °C in phosphate buffer solution at pH 7.4 during the 240 h period In this study, pH 7.4 was used as a stimulus for the release of curcumin, simulating physiological pH At pH 7.4, the−NH2
groups of chitosan (pKa = 6.3) are not ionized, while the−COOH and
−SO3H groups of the chondroitin sulfate (pKa = 2.6 and 4.5) and phenolic groups of curcumin (pKa = 8.3) are deprotonated Thus, there
is an increase in the density of negative charges, resulting in an anion-type electrostatic repulsion between the−COOH and −SO3H groups of the chondroitin sulfate and phenolic groups of curcumin This electro-static repulsion associated with the reduction of the interaction force between CHI and CS destabilizes the NPs that are formed As a con-sequence, the curcumin molecules acquire greater mobility, thus facil-itating their release into the environment (Yang et al., 2010) However, several mathematical models have been developed and studied to understand the release behavior of drugs from release sys-tems (Pal, Singh, Anis, Thakur, & Bhattacharya, 2013) In this study, the mathematical model of Gallagher-Corrigan (Gallagher & Corrigan,
2000) (Eq 2) was applied in order to elucidate the mechanism by which curcumin is released from the NPs
⎣
−
e
1
k t k t
k t k t
m m
1
2 2
Whereftis the fraction of the drug released at time t,fBis the maximum fraction of drug release,k1is the release constant at thefirst stage, tmis the maximum release time andk2 is the release constant during the degradation of the polymer
According to the mathematical model described by Gallagher-Corrigan the release of the drug from polymeric systems occurs in a two-stage process In thefirst stage (k1) a rapid release occurs due to the dissolution of the drug molecules present on the surface of the polymer matrix, and then slower release occurs due to the degradation of the polymer matrix (k2) (Gallagher & Corrigan, 2000) Thus, based on the Gallagher-Corrigan model, note that for the CHI/CS/Curc NPs, the va-lues of k1and k2obtained were equal to 0.15 and 0.02, respectively For the CHI/CS/Lecithin/Curc NPs, the values of k1and k2, obtained were: 0.26 and 0.007, respectively Thefirst stage reflects the dissolution of curcumin in the medium, controlled by diffusion, observing thus a more accelerated release of curcumin In the second stage, the percentage of release of the curcumin is slower, probably because it depends on the dissolution of the polymer over time The results clearly show the dif-ference in the release profile of curcumin caused by the addition of lecithin Although release of the curcumin occurs gradually in both NPs, the release percentage is higher for CHI/CS/Lecithin/Curc NPs in the first stage (k1), which can be attributed to the higher mean pore volume and the higher percentage of curcumin encapsulation in these nano-particles (131.8μg/mg = 87.5%), facilitating the diffusion of curcumin
to the medium
The viability of the MCF-7 human breast tumor cells from free and nanoencapsulated curcumin evaluated by the MTT assay (Fig 6) was significantly reduced (P < 0.0001), exhibiting dose-dependent cyto-toxic activity, with increased concentration of curcumin from 10 to 40 μmol.L−1
at 24, 48 and 72 h of incubation
When analyzing the effect of free curcumin, a decrease in cell via-bility was observed, by 50.0, 42.0 and 28.4% (P < 0.0001) when used
in the concentrations of 10, 20 and 40μmol.L−1
, respectively, in the
72 h period In this same period, the addition of 10μmol.L−1of CHI/ CS/Curc and CHI/CS/Lecithin/Curc NPs reduced the viability of the MCF-7 cells by 56.4 and 58.0% (P < 0.0001), respectively When adding 20μmol.L−1 of CHI/CS/Curc and CHI/CS/Lecithin/Curc NPs there was a reduction of 45.0 and 40.8% (P < 0.0001), respectively, in the viability of the cells With the addition of 40μmol.L−1of CHI/CS/ Curc and CHI/CS/Lecithin/Curc NPs, the cellular viability was reduced
to 36.0 and 30.7% (P < 0.0001), respectively, when compared to the control group
Table 2
Chemical composition of the surface (in % at) obtained by XPS for nanoparticles
and their constituents
Samples C (% at) O (% at) N (%
at)
S (% at) P (% at) O/C
(%) CHI 54.5 39.7 5.8 – – 0.7
CS 50.2 41.8 4.9 3.1 – 0.8
Curcumin 58.1 41.9 – – – 0.7
Lecithin 52.0 42.3 2.3 – 3.4 0.8
CHI/CS 52.2 40.7 4.5 2.6 – 0.7
CHI/CS/Lecithin 47.3 43.1 5.4 2.2 2.0 0.9
CHI/CS/Curc 41.2 52.7 3.7 2.4 – 1.3
CHI/CS/Lecithin/
Curc
35.6 55.4 4.9 2.0 2.1 1.6
Fig 5 Cumulative release of the curcumin from developed ( ) CHI/CS/Curc
NPs and ( ) CHI/CS/Lecithin/Curc NPs at 37 °C in phosphate buffer solution at
pH 7.4 for 240 h
Trang 8The most significant reduction in MCF-7 cell viability was observed
over the 72 h period due to the prolonged exposure of free and
na-noencapsulated curcumin in the cells, since the release of curcumin
from the formulations occurred within thefirst 24 h of treatment In
addition, increased inhibition in MCF-7 cell growth was observed for
CHI/CS/Lecithin/Curc NPs Thus, this system represents a promising
candidate for drug carrier for the treatment of breast cancer, since it has
increased the therapeutic efficacy of curcumin
In fact, the interaction with the biological medium of free and
nano-entrapped curcumin is expected to be different, since the cellular
up-take pathway of the nanoparticles is different from that of free drugs
(Ahn, Seo, Kim, & Lee, 2013) While the free curcumin has direct
contact with the cell, facilitating its diffusion into the membrane, the
nanoparticles containing curcumin penetrate the cell by endocytosis,
and the drug is liberated gradually to the medium, leading to a
re-duction in cytotoxic effect However, it is noteworthy that nanoparticles
can be accumulated in tumor regions that exhibit abnormal
vascular-ization and low lymphatic drainage (effect of improved permeability
and retention - EPR) When accumulating in the area of interest, these
nanoparticles should not only gradually release a high amount of the
drug at the target site, but also minimize side effects in normal tissues
and, as a result, decrease systemic toxicity (Hiroshi, Hideaki, & Jun,
2013)
In the control experiments performed to evaluate the toxicity of the
release system in the 24, 48 and 72 h periods (data not shown), it was
observed that the addition of CHI/CS and CHI/CS/Lecithin NPs without
the presence of curcumin did not alter the viability of the MCF-7 cells It
was especially notable that they did not present toxicity to the cells,
indicating the biocompatibility of the nanoparticles
Observations in the transmission electron microscope (Fig 7)
showed that after 24 h of exposure the free curcumin and curcumin
released through the CHI/CS/Lecithin/Curc NPs were internalized in the cytoplasm of the MCF-7 cells, thus presenting signs of cytotoxicity The main ultrastructural changes in all treated groups were chromatin aggregation, mitochondrial denaturation, autophagy vesicle and apop-totic body formation, as well as cytoplasmic compartments, swelling and disappearance of mitochondrial cristae
The therapeutic potential of curcumin as a cytotoxic agent has been extensively studied in recent years Several studies show that curcumin has distinct cytotoxicity profiles, depending on the cellular tissue and its concentration (Hanahan & Weinberg, 2011) In relation to human breast cancer, studies carried out byBayomi et al., 2013;Bozta et al.,
2013; Zhi-Dong et al., 2014demonstrated that curcumin is an anti-proliferative, cytotoxic and anti-metastatic agent The authors also evaluated the cytotoxic activity of free and encapsulated curcumin in nanoparticles in this cell line, obtaining profiles of cellular viability similar to those obtained in our study
4 Conclusions
The use of the ionic gelation technique together with the speciation study favored obtaining NPs with low PDI, hydrodynamic diameter in the nanometer range, positive zeta potential with high modulus value (+60 mV), and spherical and heterogeneous morphology However, it was observed that the CHI/CS/Lecithin NPs presented better char-acteristics for encapsulation and release of curcumin When lecithin was added, the NPs presented higher colloidal stability at the con-ditioning temperature (37 °C) during the 90-day period In addition, the amount of curcumin encapsulated in CHI/CS/Lecithin/Curc NPs was 131.8μg/mg, corresponding to 87.5 ± 0.5%, where their release oc-curred more rapidly, via a dissolution mechanism followed by slower release, as a result of degradation of the polymers In the cell viability
Fig 6 Percentage of cell viability of MCF-7 after 24 h, 48 h and 72 h of incubation Viability assay by MTT Ultrapure water was used as negative control Significantly different from the control: *P < 0.0001
Fig 7 Transmission electron micrographs obtained for MCF-7 cells treated with 40μmol.L−1of: (A) Control, (B) Curcumin and (C) CHI/CS/Lecithin/Curc NPs for
24 h with different magnifications Abbreviations: Nucleus (N); Mitochondria (M); Autophagic vesicle (arrow); Aggregation chromatin (arrow head closed); Apoptotic bodies (arrow head cast)
Trang 9assay, it was also observed that the presence of the surfactant promotes
a greater cytotoxic effect for curcumin encapsulated in NPs, presenting
a more significant reduction in the viability of human breast tumor cells
(MCF-7) when compared to the control group This indicates that the
addition of lecithin is an excellent strategy to improve the properties of
the NPs, making them a highly promising in vitro encapsulation and
controlled release system for hydrophobic substances, such as
cur-cumin
Acknowledgements
The authors gratefully acknowledgefinancial support from Brazilian
Agencies: Conselho Nacional de Desenvolvimento Científico e
Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de
Nível Superior (CAPES), Fundação de Apoio à Pesquisa do Distrito
Federal (FAPDF), Decanato de Pesquisa e Inovação (DPI-UnB),
Financiadora de Estudos e Projetos (FINEP) and Laboratório
Multiusuário de Microscopia de Alta Resolução (LabMic-UFG) for TEM
measurements
References
Ahn, S., Seo, E., Kim, K., & Lee, S J (2013) Controlled cellular uptake and drug efficacy
of nanotherapeutics Scientific Reports, 3(1997), 1–10
Akbar, M U., Zia, K M., Nazir, A., Iqbal, J., Ejaz, S A., & Akash, M S H (2018).
Pluronic-based mixed polymeric micelles enhance the therapeutic potential of
cur-cumin AAPS PharmSciTech, 19(6), 2719–2739
Alvarenga, E S (2011) Biotecnology of biopolymers (1st ed.) InTech (Chapter 5)
Anitha, A., Deepagan, V G., Divya Rani, V V., Menon, D., Nair, S V., & Jayakumar, R.
(2011) Preparation, characterization, in vitro drug release and biological studies of
curcumin loaded dextran sulphate–chitosan nanoparticles Carbohydrate Polymers, 84,
1158–1164
Banik, N., Hussain, A., Ramteke, A., Sharma, H K., & Maji, T K (2012) Preparation and
evaluation of the effect of particle size on the properties of chitosan-montmorillonite
nanoparticles loaded with isoniazid RSC Advances, 2, 10519–10528
Bayomi, S M., El-Kashef, H A., ELl-Ashmawy, M B., Nasr, M N., El-Sherbeny, M A.,
Badria, F A., et al (2013) Synthesis and biological evaluation of new curcumin
derivatives as antioxidant and antitumor agents Medicinal Chemistry Research, 22,
1147–1162
Biswas, S., Chattopadhyay, M., Sen, K K., & Saha, M K (2015) Development and
characterization of alginate coated low molecular weight chitosan nanoparticles as
new carriers for oral vaccine delivery in mice Carbohydrate Polymers, 121, 403–410
Bozta, A O., Karakuzu, O., Galante, G., Ugur, Z., Kocabas, F., Altuntas, C G., et al (2013).
Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer
com-plexation in human cancer cells Molecular Pharmaceutics, 10, 2676–2683
Calaf, G M., Ponce-Cusi, R., & Carrión, F (2018) Curcumin and paclitaxel induce cell
death in breast cancer cell lines Oncology Reports, 40(4), 2381–2388
Campos, A F C., Tourinho, F A., Da Silva, G J., Lara, M C F L L., & Depeyrot, J.
(2001) Nanoparticles superficial density of charge in electric double-layered
mag-netic fluid: A conductimetric and potentiometric approach European Physical Journal,
6, 29–35
Chen, L.-C., Chen, Y.-C., Su, C.-Y., Wong, W.-P., Sheu, M.-T., & Ho, H.-O (2016).
Development and Characterization of lecithin-based self-assembling mixed polymeric
micellar (saMPMs) drug delivery systems for curcumin Scientific Reports, 6, 1–11
Cheng, C Y., Oh, H., Wang, T Y., Raghavan, S R., & Tung, S H (2014) Mixtures of
lecithin and bile salt can form highly viscous wormlike micellar solutions in water.
Langmuir, 30, 10221–10230
Chuah, L H., Roberts, C J., Billa, N., Abdullah, S., & Rosli, R (2014) Cellular uptake and
anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Colloids and Surfaces B: Biointerfaces, 116, 228–236
Dai, L., Wei, Y., Sun, C., Mao, L., McClements, D J., & Gao, Y (2018) Development of
protein-polysaccharide-surfactant ternary complex particles as delivery vehicles for
curcumin Food Hydrocolloids, 85, 75–85
Davatgaran-Taghipour, Y., Masoomzadeh, S., Farzaei, M H., Bahramsoltani, R.,
Karimi-Soureh, Z., Rahimi, R., et al (2017) Polyphenol nanoformulations for cancer
therapy: Experimental evidence and clinical perspective International Journal of
Nanomedicine, 12, 2689–2702
Dammak, I., & Sobral, P J A (2018) Formulation optimization of lecithin-enhanced
pickering emulsions stabilized by chitosan nanoparticles for hesperidin
encapsula-tion Journal of Food Engineering, 229, 2–11
Fan, W., Yan, W., Xu, Z., & Ni, H (2012) Formation mechanism of monodisperse, low
molecular weight chitosan nanoparticles by ionic gelation technique Colloids and
Surfaces B: Biointerfaces, 90, 21–27
Farris, S., Mora, L., Capretti, G., & Piergiovanni, L (2012) Charge density quantification
of polyelectrolyte polysaccharides by conductometric titration: An analytical
chem-istry experiment Journal of Chemical Education, 89, 121–124
Gallagher, K M., & Corrigan, O I (2000) Mechanistic aspects of the release of levamisole
hydrochloride from biodegradable polymers Journal of Controlled Release, 69,
261–272
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M (2008) A review of stimuli-re-sponsive nanocarriers for drug and gene delivery Journal of Controlled Release, 126, 187–204
Guilherme, M R., Reis, A V., Alves, B R V., Kunita, M H., Rubira, A F., & Tambourgi, E.
B (2010) Smart hollow microspheres of chondroitin sulfate conjugates and mag-netite nanoparticles for magnetic vector Journal of Colloid and Interface Science, 352, 107–113
Gul, R., Ahmed, N., Ullah, N., Khan, M I., Elaissari, A., & Rehman, A (2018) Biodegradable ingredient-based emulgel loaded with ketoprofen nanoparticles AAPS PharmSciTech, 9(4), 1869–1881
Hanahan, D., & Weinberg, R (2011) Hallmarks of cancer: The next generation Cell, 144, 646–674
Heger, M (2017) Don’t discount all curcumin trial data Nature, 543, 40
Hiroshi, M., Hideaki, N., & Jun, F (2013) The EPR effect for macromolecular drug de-livery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Advanced Drug Delivery Reviews, 65, 71–79
Hu, C., Chiang, C., Hong, P., & Yeh, M (2012) Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers International Journal of Nanomedicine, 7, 4861–4872
Jardim, K V., Joanitti, G A., Azevedo, R B., & Parize, A L (2015) Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chon-droitin sulfate nanoparticles Materials Science and Engineering C, 56, 294–304
Khan, N., & Brettmann, B (2019) Intermolecular interactions in polyelectrolyte and surfactant complexes in solution Polymers, 11, 51
Krichen, F., Bougatef, H., Sayari, N., Capitani, F., Ben Amor, I., Koubaa, I., et al (2018) Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties Carbohydrate Polymers, 197, 451–459
Kumari, A., Yadav, S K., & Yadav, S C (2010) Biodegradable polymeric nanoparticles based drug delivery systems Colloids and Surfaces B-Biointerfaces, 75, 1–18
Li, R W., Liu, Q Y., Wu, H W., Wang, K., Li, L H., Zhou, C R., et al (2018) Preparation and characterization of in-situ formable liposome/chitosan composite hydrogels Materials Letters, 220, 289–292
Lim, L M., Tran, T T., Wong, J J L., Wang, D P., Cheow, W S., & Hadinoto, K (2018) Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose ex-hibiting built-in solubility enhancement and physical stability of curcumin Colloids and Surfaces B: Biointerfaces, 167, 483–491
Lu, W., Le, X., Zhang, J., Huang, Y., & Chen, T (2017) Supramolecular shape memory hydrogels: A new bridge between stimuli-responsive polymers and supramolecular chemistry Chemical Society Reviews, 46, 1284–1294
Maldonado, E A L., Terán, A O., & Guzmán, M T O (2012) A multiparameter colloidal titrations for the determination of cationic polyelectrolytes Journal of Environmental Protection, 3, 1559–1570
Marturano, V., Cerruti, P., Giamberini, M., Tylkowski, B., & Ambrogi, V (2017) Light-responsive polymer micro- and nano-capsules Polymers, 9(1), 8
Menegucci, J D S., Santos, M.-K M S., Dias, D J S., Chaker, J A., & Sousa, M H (2015) One-step synthesis of magnetic chitosan for controlled release of 5-hydro-xytryptophan Journal of Magnetism and Magnetic Materials, 380, 117–124
Mohamed, S A., El-Shishtawy, R M., Al-Bar, O A M., & Al-Najada, A R (2017) Chemical modification of curcumin: Solubility and antioxidant capacity International Journal of Food Properties, 20(3), 718–724
Nelson, K M., Dahlin, J L., Bisson, J., Graham, J., Pauli, G F., & Walters, M A (2017) The essential medicinal chemistry of curcumin Journal of Medicinal Chemistry, 60, 1620–1637
Pal, K., Singh, V K., Anis, A., Thakur, G., & Bhattacharya, M K (2013) Hydrogel-based controlled release formulations: Designing considerations, characterization techni-ques and applications Polymer-Plastics Technology and Engineering, 52, 37–41
Parize, A L., Heller, M., Favere, V T., Laranjeira, M C M., Brighente, I M C., Micke, G A., et al (2009) Impregnation of chitosan microspheres with the natural dye Curcuma Latin American Journal of Pharmacy, 28(1), 19–26
Parize, A L., Stulzer, H K., Laranjeira, M C M., Brighente, I M D., & Souza, T C R (2012) Evaluation of chitosan microparticles containing curcumin and crosslinked with sodium tripolyphosphate produced by spray drying Quimica Nova, 35, 1127–1132
Pawar, K R., & Babu, R J (2014) Lipid materials for topical and transdermal delivery of nanoemulsions Critical Reviews in Therapeutic Drug Carrier Systems, 31(5), 429–458
Rodrigues, S., Cardoso, L., Da Costa, A M R., & Grenha, A (2015) Biocompatibility and stability of polysaccharide polyelectrolyte complexes aimed at respiratory delivery Materials, 8, 5647–5670
Rodrigues, S., Da Costa, A M R., & Grenha, A (2012) Chitosan/carrageenan nano-particles: Effect of cross-linking with tripolyphosphate and charge ratios Carbohydrate Polymers, 89, 282–289
Scordilis-Kelley, C., & Osteryoung, J C (1996) Voltammetric studies of counterion transport in solutions of chondroitin sulfate The Journal of Physical Chemistry, 100, 797–804
Şenyiğit, T., Sonvico, F., Rossi, A., Tekmen, I., Santi, P., Colombo, P., et al (2017) In vivo assessment of clobetasol propionate-loaded lecithin-chitosan nanoparticles for skin delivery International Journal of Molecular Sciences, 18(1), 32
Shin, G H., Chung, S K., Kim, J T., Joung, H J., & Park, H J (2013) Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of cur-cumin using the ethanol injection method Journal of Agricultural and Food Chemistry, 61(46), 11119–11126
Siddiqui, F A., Prakasam, G., Chattopadhyay, S., Rehman, A U., Padder, R A., Ansari, M A., et al (2018) Curcumin decreases Warburg effect in cancer cells by down-reg-ulating pyruvate kinase M2 via mTOR-HIF1α inhibition Scientific Reports, 8, 8323
Silva, S M C., Antunes, F E., Sousa, J J S., Valente, A J M., & Pais, A A C C (2011).
Trang 10New insights on the interaction between hydroxypropylmethyl cellulose and sodium
dodecyl sulfate Carbohydrate Polymers, 86, 35–44
Sing, K S., Everett, D H., Haul, R A W., Moscou, L., Pierotti, R A., Rouqueirol, J., et al.
(1985) Reporting physisorption data for gas/solid systems: With specil reference to
the determination of surface area and porosity Pure and Applied Chemistry, 57(4),
603–619
Silva, M C., Fideles, T B., & Fook, M V L (2015) Esferas de quitosana e quitosana/
curcumina pelo método de gelificação ionotrópica: influência da incorporação do
fármaco Revista Eletrônica de Materiais e Processos, 10(1), 21–28
Sonvico, F., Cagnani, A., Rossi, A., Motta, S., Di Bari, M T., Cavatorta, F., et al (2006).
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction.
International Journal of Pharmaceutics, 324, 67–73
Souza, M P., Vaz, A F M., Correia, M T S., Cerqueira, M A., Vicente, A A., &
Carneiro-da-Cunha, M G (2014) Quercetin-loaded lecithin/chitosan nanoparticles for
func-tional food applications Food Bioprocess Technol, 7, 1149–1159
Sun, C., Me, Y C., Tian, Q L., & Liu, H (2007) Separation of glycyrrhizic acid and
liquiritin from licorice root by aqueous nonionic surfactant mediated extraction.
Colloids and Surfaces A-Physicochemical and Engineering Aspects, 305, 42–47
Sun, C., Liu, F., Yang, J., Yang, W., Yuan, F., & Gao, Y (2015) Physical, structural,
thermal and morphological characteristics of zein quercetagetin composite colloidal
nanoparticles Industrial Crops and Products, 77, 476–483
Tan, C., Selig, M J., & Abbaspourrad, A (2018) Anthocyanin stabilization by
chitosan-chondroitin sulfate polyelectrolyte complexation integrating catechin
co-pigmenta-tion Carbohydrate Polymers, 181, 124–131
Taner, G., Yesiloz, R., Vardar, D O., Senyigit, T., Ozgen, O., Degen, G H., et al (2014).
Evaluation of the cytotoxic and genotoxic potential of lecithin/chitosan
nanoparticles Journal of Nanoparticle Research, 16, 2216–2220
Terrón-Mejía, K A., Martínez-Benavidez, E., Higuera-Ciapara, I., Virués, C., Hernández, J., Domínguez, Z., et al (2018) Mesoscopic modeling of the encapsulation of cap-saicin by lecithin/chitosan liposomal nanoparticles Nanomaterials, 8(6), 425
Tsai, M.-L., Chen, R.-H., Bai, S.-W., & Chen, W.-Y (2011) The storage stability of chit-osan/tripolyphosphate nanoparticles in a phosphate buffer Carbohydrate Polymers,
84, 756–761
Tsai, H Y., Chiu, C C., Lin, P C., Chen, S H., Huang, S J., & Wang, L F (2011) Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chon-droitin sulfate/chitosan polyelectrolyte complexes Macromolecular Bioscience, 11, 680–688
Umerska, A., Corrigan, O I., & Tajber, L (2017) Design of chondroitin sulfate-based polyelectrolyte nanoplexes: Formation of nanocarriers with chitosan and a case study
of salmon calcitonin Carbohydrate Polymers, 156, 276–284
Wen, F., Wen, F., Wei, Y., Zushun, X., & Hong, N (2012) Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation tech-nique Colloids and Surfaces B: Biointerfaces, 90, 21–27
Yang, S., Dai, L., Sun, C., & Gao, Y (2018) Characterization of curcumin loaded gliadin-lecithin composite nanoparticles fabricated by antisolvent precipitation in different blending sequences Food Hydrocolloids, 82, 185–194
Yang, Y J., Tao, X., Hou, Q., Maa, Y., Chen, X L., & Chen, J F (2010) Mesoporous silica nanotubes coated with multilayered polyelectrolytes for pH-controlled drug release Acta Biomaterialia, 6, 3092–3100
Zhi-Dong, L., Xiang-Ping, L., Wei-Jun, Z., Qian, D., Fu-Nian, L., Hai-Bo, W., et al (2014) Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo International Journal of Clinical and Experimental Pathology, 7, 2818–2824